Yasunori Kaneko
Directeur/Membre du Conseil chez ARCUS BIOSCIENCES, INC.
Fortune : 13 M $ au 30/04/2024
Provenance du réseau au premier degré de Yasunori Kaneko
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 38 | |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA.
15
| Extinct | Miscellaneous Commercial Services | 15 |
Public Company | Industrial Specialties | 11 | |
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California.
8
| Private Company | Investment Managers | 8 |
Paribas Capital Markets
6
| Extinct | Investment Banks/Brokers | 6 |
Public Company | Pharmaceuticals: Major | 5 | |
Provigate KK
Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan.
2
| Holding Company | Medical Specialties | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Yasunori Kaneko via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal General Counsel General Counsel Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Consultant / Advisor | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman President Chief Operating Officer Chief Tech/Sci/R&D Officer | |
University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO Comptroller/Controller/Auditor | |
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Founder | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Public Communications Contact | |
University of Michigan | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Amsterdam | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
PACT Pharma, Inc.
PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder Founder Founder | |
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Human Resources Officer Private Equity Investor | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer Corporate Officer/Principal | |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO | |
University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Investor Relations Contact | |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
U.S. House of Representatives | General Government | General Counsel General Counsel | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
University of Maryland | College/University | Doctorate Degree Graduate Degree | |
SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Novasys Medical, Inc.
Novasys Medical, Inc. Medical/Nursing ServicesHealth Services Novasys Medical, Inc. develops therapies for women's health. The company was founded by Stuart D. Edwards and Peter S. Edelstein on June 24, 1999 and is headquartered in Newark, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
University of California, Los Angeles | College/University | Undergraduate Degree Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
GENOCEA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
ARCA BIOPHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
The University of Colorado School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Stanford Law School | College/University | Graduate Degree Graduate Degree | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal Chief Executive Officer | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member |
Statistiques
Internationale
Etats-Unis | 49 |
Pays-Bas | 2 |
Espagne | 2 |
Sectorielle
Health Technology | 34 |
Consumer Services | 12 |
Finance | 3 |
Commercial Services | 3 |
Government | 2 |
Opérationnelle
Director/Board Member | 342 |
Corporate Officer/Principal | 167 |
Independent Dir/Board Member | 106 |
Chief Tech/Sci/R&D Officer | 57 |
Undergraduate Degree | 50 |
Relations les plus connectées
Insiders | |
---|---|
Stephen J. Hoffman | 33 |
Kathryn Falberg | 30 |
Clarence Machado | 30 |
Camille Samuels | 30 |
Dan Kisner | 29 |
Mark Levin | 26 |
Patrick Baeuerle | 19 |
Leon E. Chen | 19 |
David G. Lowe | 19 |
Terry Rosen | 19 |
Jennifer Jarrett | 18 |
B. Parshall | 17 |
John McLaughlin | 17 |
Rekha Hemrajani | 17 |
Kristen Hege | 17 |
- Bourse
- Insiders
- Yasunori Kaneko
- Connexions Sociétés